{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T19:36:47Z","timestamp":1770493007146,"version":"3.49.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,2]]},"DOI":"10.7759\/cureus.102845","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T19:52:58Z","timestamp":1770061978000},"source":"Crossref","is-referenced-by-count":0,"title":["Severe Hidradenitis Suppurativa and Subsequent Myelodysplastic Syndrome: A Case Report Highlighting Chronic Inflammatory Burden and Carcinogenic Risk"],"prefix":"10.7759","author":[{"given":"Mariela R","family":"Rosas Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guadalupe","family":"Maldonado-Colin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Achell Nava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianka D","family":"Barajas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramiro","family":"Alanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0149-1","article-title":"Hidradenitis suppurativa","volume":"6","author":"Sabat R","year":"2020","unstructured":"Sabat R, Jemec GB, Matusiak \u0141, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020, 6:18. 10.1038\/s41572-020-0149-1","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2023.08.021","article-title":"Hidradenitis suppurativa and follicular occlusion syndrome: where is the pathogenetic link?","volume":"41","author":"Jastrz\u0105b B","year":"2023","unstructured":"Jastrz\u0105b B, Szepietowski JC, Matusiak \u0141. Hidradenitis suppurativa and follicular occlusion syndrome: where is the pathogenetic link?. Clin Dermatol. 2023, 41:576-83. 10.1016\/j.clindermatol.2023.08.021","journal-title":"Clin Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2382372","article-title":"A state-of-the-art systematic review of cancer in hidradenitis suppurativa","volume":"56","author":"Abu Rached N","year":"2024","unstructured":"Abu Rached N, R\u00fcth J, Gambichler T, Ocker L, Bechara FG. A state-of-the-art systematic review of cancer in hidradenitis suppurativa. Ann Med. 2024, 56:2382372. 10.1080\/07853890.2024.2382372","journal-title":"Ann Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S512373","article-title":"Hidradenitis suppurativa cancer risk: a review of the literature","volume":"18","author":"Martora F","year":"2025","unstructured":"Martora F, Tommasino N, Battista T, Potestio L, Megna M. Hidradenitis suppurativa cancer risk: a review of the literature. Clin Cosmet Investig Dermatol. 2025, 18:617-26. 10.2147\/CCID.S512373","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.11.012","article-title":"Hidradenitis suppurativa in acute myeloid leukemia: review of disease course and management","volume":"19","author":"Chen SX","year":"2022","unstructured":"Chen SX, Lopez CG, Kassamali B, Luskin MR, Charrow A. Hidradenitis suppurativa in acute myeloid leukemia: review of disease course and management. JAAD Case Rep. 2022, 19:44-7. 10.1016\/j.jdcr.2021.11.012","journal-title":"JAAD Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten FR","year":"2019","unstructured":"Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019, 51:27-41. 10.1016\/j.immuni.2019.06.025","journal-title":"Immunity"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani A","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008, 454:436-44. 10.1038\/nature07205","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1126\/science.1196284","article-title":"Gamma-secretase gene mutations in familial acne inversa","volume":"330","author":"Wang B","year":"2010","unstructured":"Wang B, Yang W, Wen W, et al.. Gamma-secretase gene mutations in familial acne inversa. Science. 2010, 330:1065. 10.1126\/science.1196284","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2020.06.019","article-title":"A systematic review of promising therapeutic targets in hidradenitis suppurativa: a critical evaluation of mechanistic and clinical relevance","volume":"141","author":"Frew JW","year":"2021","unstructured":"Frew JW, Marzano AV, Wolk K, Join-Lambert O, Alavi A, Lowes MA, Piguet V. A systematic review of promising therapeutic targets in hidradenitis suppurativa: a critical evaluation of mechanistic and clinical relevance. J Invest Dermatol. 2021, 141:316-324.e2. 10.1016\/j.jid.2020.06.019","journal-title":"J Invest Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-024-03121-x","article-title":"The use of biologics and JAK inhibitors in the management of moderate to severe Hidradenitis Suppurativa treatment: a scoping review","volume":"316","author":"Guermazi D","year":"2024","unstructured":"Guermazi D, Shah A, Yumeen S, Saliba E. The use of biologics and JAK inhibitors in the management of moderate to severe Hidradenitis Suppurativa treatment: a scoping review. Arch Dermatol Res. 2024, 316:259. 10.1007\/s00403-024-03121-x","journal-title":"Arch Dermatol Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/460023-severe-hidradenitis-suppurativa-and-subsequent-myelodysplastic-syndrome-a-case-report-highlighting-chronic-inflammatory-burden-and-carcinogenic-risk","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T19:52:59Z","timestamp":1770061979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/460023-severe-hidradenitis-suppurativa-and-subsequent-myelodysplastic-syndrome-a-case-report-highlighting-chronic-inflammatory-burden-and-carcinogenic-risk"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.102845","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,2]]}}}